Skip to main content
. 2022 Sep 9;14(9):1914. doi: 10.3390/pharmaceutics14091914

Figure 3.

Figure 3

FDA-approved drugs for the treatment of Alzheimer’s disease. Small molecules (tacrine, memantine, rivastigmine, donepezil, and galantamine) and the monoclonal antibody aducanumab (where chain A is shown in green, chain B in blue and chain C in cyan.) PDB code: 6CO3 [68].